Luis
Madero Lopez
Hospital Vall d'Hebron
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Vall d'Hebron (23)
2022
2021
2018
-
Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care
Journal of Neuro-Oncology, Vol. 137, Núm. 1, pp. 205-213
2017
-
Early clinical trials in paediatric oncology in Spain: a nationwide perspective
Anales de Pediatria, Vol. 87, Núm. 3, pp. 155-163
2016
-
Landscape of early clinical trials for childhood and adolescence cancer in Spain
Clinical and Translational Oncology, Vol. 18, Núm. 7, pp. 708-713
2013
-
Actualización del tratamiento con L-asparraginasa en Pediatría
Anales de Pediatria, Vol. 79, Núm. 5
-
Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse
American Journal of Hematology, Vol. 88, Núm. 5, pp. 359-364
-
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: A joint ITCC and SIOPE brain tumor study
Neuro-Oncology, Vol. 15, Núm. 9, pp. 1236-1243
2011
-
Guidelines for the treatment of invasive candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 5, pp. 345-361
-
Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454
-
Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update
Enfermedades Infecciosas y Microbiologia Clinica
2009
-
Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from fanconi anemia patients
Molecular Therapy, Vol. 17, Núm. 6, pp. 1083-1092
2008
-
Update on pulmonary infections in patients with hematologic malignancies and hematopoietic stem cell recipients
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 3, pp. 58-71
2006
-
A simplified approach to improve the efficiency and safety of ex vivo hematopoietic gene therapy in fanconi anemia patients
Human Gene Therapy, Vol. 17, Núm. 2, pp. 245-250
2005
-
Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998
Bone Marrow Transplantation, Vol. 35, Núm. 9, pp. 895-901
2002
-
Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia
Bone Marrow Transplantation, Vol. 30, Núm. 1, pp. 9-13
2000
-
Autologous stem cell transplantation for advanced Hodgkin's disease in children
Bone Marrow Transplantation, Vol. 25, Núm. 1, pp. 31-34
-
Trasplante de progenitores hematopoyéticos de sangre de cordón umbilical en niños
Anales Espanoles de Pediatria, Vol. 53, Núm. 6, pp. 513-519
1999
-
Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia
Haematologica, Vol. 84, Núm. 2, pp. 133-137
-
Trasplante alogenico de medula osea en ninos con aplasia medular grave adquirida. Resultados a largo plazo
Anales Espanoles de Pediatria, Vol. 50, Núm. 1, pp. 29-32